Related Experiment Video
Updated: Jun 23, 2026

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
Cystatin C provides more information than other renal function parameters for stratifying risk in patients with acute
José M García Acuña1, Eva González-Babarro, Lilian Grigorian Shamagian
1Servicio de Cardiología y Unidad Coronaria, Departamento de Medicina, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain. jose.maria.garcia.acuna@sergas.es
Insights
Elevated cystatin C levels in acute coronary syndrome (ACS) patients indicate a higher risk of heart failure and mortality. This biomarker aids in risk stratification, especially for those with normal kidney function.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- Cystatin C, a protein with stable plasma concentration cleared by kidneys, is a potential prognostic marker.
- Acute coronary syndrome (ACS) requires accurate risk stratification for optimal patient management.
Purpose of the Study:
- To evaluate the prognostic value of serum cystatin C levels in patients diagnosed with ACS.
- To determine if cystatin C can predict adverse outcomes in ACS patients.
Main Methods:
- Prospective study of 203 hospitalized ACS patients.
- Clinical data, hemogram, creatinine, cystatin C, lipids, and cardiac markers were collected within 24 hours.
- Glomerular filtration rate (GFR) estimated using MDRD equation; patients grouped by cystatin C >0.95 mg/L.
Main Results:
- Patients with cystatin C >0.95 mg/L showed significantly higher rates of heart failure (51.3% vs 13.3%) and in-hospital mortality (17.6% vs 3.3%).
- Cystatin C was identified as a powerful independent predictor of cardiovascular events (RR=1.91).
- Even with normal GFR (>60 mL/1.73 m²), elevated cystatin C correlated with increased in-hospital mortality (10.2% vs 3.9%).
Conclusions:
- Serum cystatin C measurement is clinically valuable for risk stratification in high-risk ACS patients.
- Cystatin C provides prognostic information particularly useful in ACS patients with normal GFR.
- This biomarker can enhance early identification of patients at risk for adverse cardiovascular outcomes.
Introduction And Objectives:
The protein cystatin C has a stable plasma concentration and is eliminated exclusively by the kidneys. The aim of this study was to determine the prognostic value of cystatin C in patients with acute coronary syndrome (ACS).
Methods:
The prospective study included 203 hospitalized ACS patients. Clinical evaluation during the first 24 hours of hospitalization included a hemogram and measurement of creatinine, cystatin C, total and fractionated cholesterol and markers of myocardial necrosis. The glomerular filtration rate (GFR) was estimated using the MDRD (Modification of Diet in Renal Disease) equation. A comparison was made between two groups of patients divided according to a serum cystatin-C level above or below 0.95 mg/L. The mean follow-up period was 151 days.
Results:
In total, 90 patients (44.3%) had a cystatin-C level < or =0.95 mg/L and 113 (55.7%) had a level >0.95 mg/L. Those with a cystatin-C level >0.95 mg/L had poorer in-hospital outcomes, including more frequent heart failure (51.3% vs. 13.3%; P=.001) and higher in-hospital mortality (17.6% vs. 3.3%; P=.001), as well as higher mortality throughout follow-up (22.0% vs. 5.6%; P=.001). Multivariate analysis adjusted for age, ejection fraction and troponin-I and high-sensitivity C-reactive protein concentrations showed that cystatin C was the most powerful independent predictor of a cardiovascular event (relative risk=1.91; 95% confidence interval, 1.03-3.53). Patients with a GFR >60 mL/1.73 m(2) and a cystatin-C level >0.95 mg/L had higher in-hospital mortality (10.2% vs. 3.9%; P=.001).
Conclusions:
Measurement of cystatin C in high-risk ACS patients may be clinically useful for risk stratification during hospitalization, particularly in those with a normal GFR.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Serum Studies: Renal Function Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Kidney Injury IV: Diagnostic Studies and Prevention